This notion is consistent with previous observations that interfering with TGF-β signaling inhibits integrin expression and TGF-β-induced metastasis of breast cancer cells [46], and that expression of αvβ3 integrin is a key determinant for homing of breast cancer cells to bone [47]. The gene discussed is TGFB1; the disease is breast carcinoma.